For ER+ breast cancer, the selection criteria revealed eight cell types: iCAF, myCAF, cancer luminal A, macrophages, ACKR1+ ECs, differentiated PVLs, CD4+ T cells and CD8+T cells. This evidence concerns the gene CD8A and breast carcinoma.